SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001140361-22-010440
Filing Date
2022-03-22
Accepted
2022-03-22 07:03:18
Documents
14
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 6-K brhc10035397_6k.htm 6-K 18066
2 EXHIBIT 99.1 brhc10035397_ex99-1.htm EX-99.1 239793
3 EXHIBIT 99.2 brhc10035397_ex99-2.htm EX-99.2 1467928
4 EXHIBIT 99.3 brhc10035397_ex99-3.htm EX-99.3 480778
5 EXHIBIT 99.4 brhc10035397_ex99-4.htm EX-99.4 218186
6 image00001.jpg GRAPHIC 2372
7 image00002.jpg GRAPHIC 2313
8 image3.jpg GRAPHIC 12958
9 image00005.jpg GRAPHIC 2914
10 image00008.jpg GRAPHIC 2504
11 image00010.jpg GRAPHIC 8101
12 image00012.jpg GRAPHIC 3730
13 image00013.jpg GRAPHIC 2386
14 image00014.jpg GRAPHIC 7878
  Complete submission text file 0001140361-22-010440.txt   2489007
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 22757168
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences